Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surveillance after Focal Therapy - a Comprehensive Review.
Marra G, Marquis A, Suberville M, Woo H, Govorov A, Hernandez-Porras A, Bhatti K, Turkbey B, Katz AE, Polascik TJ. Marra G, et al. Among authors: woo h. Prostate Cancer Prostatic Dis. 2024 Oct 4. doi: 10.1038/s41391-024-00905-0. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39367182 Review.
Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different biopsy scenarios.
Chiam K, Carle C, Hughes S, Kench JG, Woo HH, Lord S, Smith DP. Chiam K, et al. Among authors: woo hh. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):662-673. doi: 10.1038/s41391-021-00320-9. Epub 2021 Mar 2. Prostate Cancer Prostatic Dis. 2021. PMID: 33654249 Review.
"TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now.
Grummet J, Gorin MA, Popert R, O'Brien T, Lamb AD, Hadaschik B, Radtke JP, Wagenlehner F, Baco E, Moore CM, Emberton M, George AK, Davis JW, Szabo RJ, Buckley R, Loblaw A, Allaway M, Kastner C, Briers E, Royce PL, Frydenberg M, Murphy DG, Woo HH. Grummet J, et al. Among authors: woo hh. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):62-65. doi: 10.1038/s41391-020-0204-8. Epub 2020 Jan 13. Prostate Cancer Prostatic Dis. 2020. PMID: 31932659 Free PMC article. Review. No abstract available.
The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
Woo HH, Huang CP, Huang WJ, Chang YH, Lien CS, Chkhotua A, Elterman DS. Woo HH, et al. Prostate Cancer Prostatic Dis. 2022 Sep;25(3):576-582. doi: 10.1038/s41391-022-00548-z. Epub 2022 May 31. Prostate Cancer Prostatic Dis. 2022. PMID: 35641601 Free PMC article. Clinical Trial.
2,547 results